Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
China General Plastics Corporation (1305.TW)
Taipei, TW
China General Plastics Corporation (CGPC) is a global manufacturer, distributor, and service provider specializing in a diverse array of vinyl products. Its operational reach extends across numerous continents, including Asia, North America (United States), Oceania, Europe, the Middle East, and Africa. The company's core activities are structured into two distinct business segments: Vinyl Chloride Monomer (VCM) Products and Polyvinyl Chloride (PVC) Products. CGPC's extensive portfolio encompasses both foundational raw materials and specialized fabrication items. A significant portion of its offerings includes PVC resins, which are vital for a wide range of applications such as injection and blow molding, the creation of rigid and shrinkable films through hollow vacuum forming, and the production of soft and semi-rigid goods. These resins also form the basis for rigid pipes, hoses, insulation for wires and cables, high-impact flexible products, high-impact sheets, and materials for high-voltage wiring. Furthermore, CGPC develops PVC compound products available in both soft and rigid formulations. For the construction industry, the company provides essential components like PVC pipes and fittings, waterproofing membranes, anti-corrosion liners, and various PVC wall/partition boards and panels. Its product line also extends to flexible, rigid, printed, and laminated films and sheets, alongside specialized films for furniture lamination. Additionally, CGPC produces synthetic leather products, widely utilized in diverse sectors such as footwear, furniture, marine environments, vehicles, sports equipment, and medical care applications, often featuring stain-resistant properties. Demonstrating a commitment to sustainability, the corporation also develops environmentally friendlier "green" materials, including the VERDOR GREEN leather/film, and the VERDA GREEN and POLYTEX GREEN leather lines. Established in 1964, China General Plastics Corporation maintains its corporate headquarters in Taipei, Taiwan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.38% | -1.89% | -26.42% | +9.28% | +10.21% | +18.26% | +12.61% | -44.18% | -57.03% | +10.40% | -25.87% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 1 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-16.8% Q1'26: +8.6% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-29.5% Q1'26: +54.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-8.7% Q1'26: -15.4% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%-13.7% Q1'26: -6.6% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%-9.3% Q1'26: -4.2% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.1% Q1'26: -1.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×-14.78× Q1'26: -9.66× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
13.84B
est: 13.85B (-0.1%)
|
14.16B
est: 14.18B (-0.1%)
|
14.70B
est: 14.70B (+0.0%)
|
15.19B
est: 15.15B (+0.3%)
|
15.12B
est: 15.12B (+0.0%)
|
13.73B
est: 13.49B (+1.8%)
|
20.22B
est: 20.50B (-1.4%)
|
17.64B
est: 17.87B (-1.3%)
|
13.71B
est: 12.57B (+9.1%)
|
11.09B
est: 11.16B (-0.7%)
|
9.22B
est: 9.25B (-0.3%)
|
10.21B
9.82B – 10.60B
+10.4% YoY
|
9.58B
9.39B – 9.77B
-6.2% YoY
|
| EBITDA |
1.38B
est: 1.42B (-3.0%)
|
2.28B
est: 1.46B (+56.8%)
|
2.10B
est: 1.51B (+39.3%)
|
2.10B
est: 1.56B (+34.7%)
|
1.37B
est: 1.55B (-11.5%)
|
2.80B
est: 1.38B (+102.2%)
|
3.97B
est: 2.11B (+88.4%)
|
225.08M
est: 1.84B (-87.7%)
|
1.32B
est: 652.67M (+102.1%)
|
47.93M
est: 579.71M (-91.7%)
|
-458.99M
est: 480.42M (-195.5%)
|
530.34M
510.06M – 550.63M
+10.4% YoY
|
497.56M
487.64M – 507.47M
-6.2% YoY
|
| EBIT |
916.13M
est: 712.61M (+28.6%)
|
1.87B
est: 729.41M (+157.0%)
|
1.65B
est: 756.14M (+118.3%)
|
1.57B
est: 779.70M (+101.7%)
|
773.90M
est: 777.77M (-0.5%)
|
2.14B
est: 693.98M (+209.0%)
|
3.29B
est: 1.06B (+211.9%)
|
-490.37M
est: 919.60M (-153.3%)
|
547.61M
est: -88.95M (+715.7%)
|
-826.36M
est: -79.00M (-946.0%)
|
-1.26B
est: -65.47M (-1,824.4%)
|
-72.28M
-75.04M – -69.51M
-10.4% YoY
|
-67.81M
-69.16M – -66.46M
+6.2% YoY
|
| Net Income |
767.57M
est: 692.15M (+10.9%)
|
1.44B
est: 1.31B (+9.8%)
|
1.27B
est: 1.29B (-1.7%)
|
1.28B
est: 1.36B (-6.5%)
|
642.68M
est: 631.78M (+1.7%)
|
1.63B
est: 1.10B (+48.8%)
|
2.47B
est: 2.50B (-1.2%)
|
-370.25M
est: -407.48M (+9.1%)
|
341.92M
est: 171.60M (+99.2%)
|
-709.97M
est: -460.65M (-54.1%)
|
-918.98M
est: -727.04M (-26.4%)
|
-452.00M
-786.62M – -109.09M
+37.8% YoY
|
-420.00M
-429.62M – -407.93M
+7.1% YoY
|
| SGA |
983.80M
est: 1.19B (-17.1%)
|
1.02B
est: 1.21B (-16.3%)
|
1.08B
est: 1.26B (-14.4%)
|
1.08B
est: 1.30B (-17.1%)
|
1.14B
est: 1.29B (-12.3%)
|
1.14B
est: 1.16B (-1.6%)
|
1.65B
est: 1.76B (-6.3%)
|
1.59B
est: 1.53B (+3.9%)
|
1.14B
est: 1.11B (+3.3%)
|
1.00B
est: 983.21M (+2.0%)
|
875.33M
est: 814.80M (+7.4%)
|
899.47M
865.07M – 933.88M
+10.4% YoY
|
843.87M
827.05M – 860.68M
-6.2% YoY
|
| EPS |
1.32
est: 1.19 (+10.8%)
|
2.48
est: 2.26 (+9.6%)
|
2.19
est: 2.22 (-1.5%)
|
2.20
est: 2.35 (-6.3%)
|
1.11
est: 1.09 (+2.1%)
|
2.68
est: 1.89 (+41.8%)
|
4.25
est: 4.30 (-1.2%)
|
-0.64
est: -0.70 (+8.7%)
|
0.59
est: 0.30 (+99.8%)
|
-1.22
est: -0.79 (-54.0%)
|
-1.58
est: -1.25 (-26.4%)
|
-0.77
-1.35 – -0.19
+38.4% YoY
|
-0.72
-0.74 – -0.70
+6.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.01% | 17.4K | 0.42% |
| 2 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.01% | 44.2K | 0.65% |
| 3 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 566.8K | 0.06% |
| 4 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.00% | 7.0K | 0.35% |
| 5 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 223.7K | 0.39% |
| 6 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 133.8K | 0.29% |
| 7 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 39.6K | 0.26% |
| 8 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 17.5K | 0.48% |
| 9 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 1.95M | 0.06% |
| 10 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 113.9K | 0.28% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chi-Hong Hu | President & Director | 5M | male |
| Yi-Gui Wu | Chairman & Chief Executive Officer | 4M | male |
| Chun-Feng Li | Accounting Manager | — | — |
| Hui-Xue Wu | Director of Finance Department | — | female |
| Kang Nien Chiang | Chief Internal Auditor | — | — |
| Yung-Chih Chen | Corporate Governance Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1305.TW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
